Edge Therapeutics, which is developing a sustained-release therapy for ruptured brain aneurysms, announced terms for its IPO on Monday. The Berkeley Heights, NJ-based company plans to raise $85 million by offering 5.7 million shares at a price range of $14...read more
Ten IPOs raised $1.2 billion in a week dominated by eight health care IPOs and distinguished by two deals that gained over 100% on the first day - fast casual burger chain Shake Shack and gene therapy biotech Spark Therapeutics. There were more health care IPOs...read more
Ascendis Pharma, which is developing long-acting treatments for growth hormone deficiency, raised $108 million by offering 6 million shares (vs. 5 million originally planned) at $18, the high end of the $16 to $18 range. Ascendis Pharma will list on the NASDAQ...read more
Twelve IPOs are set to raise $1 billion in the upcoming week, which would make it the busiest five-day stretch for IPOs since the week of July 28. Shake Shack's IPO offers investors a chance to own a fast-growing fast casual concept based in New York. Ten of the...read more
A cutting edge biotech: Edge Therapeutics sets terms for $85 million IPO
Edge Therapeutics, which is developing a sustained-release therapy for ruptured brain aneurysms, announced terms for its IPO on Monday. The Berkeley Heights, NJ-based company plans to raise $85 million by offering 5.7 million shares at a price range of $14...read more
US IPO Weekly Recap: Shake Shack and Spark spike over 100% in a week with 10 IPOs
Ten IPOs raised $1.2 billion in a week dominated by eight health care IPOs and distinguished by two deals that gained over 100% on the first day - fast casual burger chain Shake Shack and gene therapy biotech Spark Therapeutics. There were more health care IPOs...read more
Ascendis Pharma prices upsized IPO at $18, the high end of the range
Ascendis Pharma, which is developing long-acting treatments for growth hormone deficiency, raised $108 million by offering 6 million shares (vs. 5 million originally planned) at $18, the high end of the $16 to $18 range. Ascendis Pharma will list on the NASDAQ...read more
Week ahead: IPO market gains momentum with 12 deals including Shake Shack and health care
Twelve IPOs are set to raise $1 billion in the upcoming week, which would make it the busiest five-day stretch for IPOs since the week of July 28. Shake Shack's IPO offers investors a chance to own a fast-growing fast casual concept based in New York. Ten of the...read more